OccamzRazor

Artificial Intelligence, Biotechnology, Machine Learning, Neuroscience
Founded in 1/1/15
San Francisco, California, United States
http://www.occamzrazor.com
For Profit

About OccamzRazor

OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they are designed to extract data from unstructured text sources (publications, patient reported outcomes, etc.) and join them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. Successful applications include data extraction and curation from biomedical text, novel target identification, and drug repurposing/repositioning.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 14 active products

Financial Information

  • Estimated Revenue: $1M to $10M
  • Total Funding: 12350000 USD
  • Last Funding: 6100000 USD (Series A)
  • Funding Status: Early Stage Venture

Technology Stack

OccamzRazor actively uses 14 products in their tech stack.

Market Presence

Industries: Artificial Intelligence, Biotechnology, Machine Learning, Neuroscience

Headquarters: San Francisco, California, United States

Leadership

  • Katharina Volz - CEO & Co-Founder LinkedIn
  • Robbie Narang - President and Chief Operating Officer LinkedIn

Employees

  • Berk Kapicioglu - Chief Technology Officer (LinkedIn)